16 employees
Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.
2017
$27M
from 4 investors over 4 rounds
Nocion Therapeutics, Inc. raised $27M on April 18, 2019
Investors: Mission BioCapital, Partners HealthCare, Canaan and F-Prime Capital Partners